CTLA4 and cancer: The enriched pathways encompassed various processes, including mitotic G1 Phase and G1/S transition (Fig. 2D), caspase cascade (Fig. 2E), oxidative damage response (Fig. 2F), autophagy (Fig. 2G), cancer immunotherapy by PD1 blockade (Fig. 2H), cancer immunotherapy by CTLA4 blockade (Fig. 2I), modulators of Tcr signaling and T cell activation (Fig. 2J), natural cell mediated cytotoxicity (Fig. 2K) and so on.